Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell

Qian He(Academy of Medical Sciences), Xiulan Zou(Yichang Central People's Hospital), Jun Zeng(China Three Gorges University), Xuan Xia(Sun Yat-sen University), Wei Wang(Shanghai Innovative Research Center of Traditional Chinese Medicine), Qiong Wu(Shanghai East Hospital), Renmin Tang(China Three Gorges University), Kecheng Yao(Yichang Central People's Hospital)
Life Sciences
October 28, 2019
10.1016/j.lfs.2019.117010
Cited by 28

Related Papers

Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
|PLoS ONE|2011|260
Effect of Probiotics on Glucose and Lipid Metabolism in Type 2 Diabetes Mellitus: A Meta-Analysis of 12 Randomized Controlled Trials
|Medical Science Monitor|2017|173
Risk of Dementia in Long-Term Benzodiazepine Users: Evidence from a Meta-Analysis of Observational Studies
|Journal of Clinical Neurology|2019|93
Maintenance Therapy With Continuous or Switch Strategy in Advanced Non-small Cell Lung Cancer
|CHEST Journal|2011|71
A sarcopenia index based on serum creatinine and cystatin C cannot accurately detect either low muscle mass or sarcopenia in urban community-dwelling older people
|Scientific Reports|2018|56